LiqBio biomedical company limited
Update:2026/01/07
Industries
Main Industry
Health Care
Main Product/Service
LiqBio Biomedical employs its flagship instrument CytoExplore to directly analyse and isolate rare cells from blood samples, thereby demonstrating the company’s technological strength in cancer detection, personalized medicine and new drug development.
Founded Year
2021
Unified Business No.
91096216
Status
Active
Number of Employees
0
Total Paid-in
Capital
146,250,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
The company is committed to the research and development of high-end medical analysis instrument. Independent research and development technology in Taiwan and cross-field technicians integrating molecular biology, clinical, electromechanical, optoelectro